Start with the mechanism.
Connect biological evidence to the molecular interactions that matter. Define the question before searching for an answer.
Biology first. Possibility next.
Proteins start with
methionine.
Discovery starts here.
We’re bringing artificial intelligence and biological insight together to discover what medicine could become.
AI-driven drug discoveryFrom biological questions to therapeutic possibilities
A single amino acid can mark the beginning of a protein. A better biological question can mark the beginning of a medicine.
Methionine AI is built around a simple ambition: make the path from understanding disease to designing a potential treatment more deliberate, more connected, and more informed.
Our approach
Intelligence that works
with biology.
Explore the possible.
Use computational models to investigate molecular ideas, balancing potential activity with the properties a medicine needs.
Let evidence lead.
Use experimental findings to challenge predictions, refine hypotheses, and make the next discovery cycle more informative.
Research philosophy
A prediction is
the beginning.
Evidence is the path.
The value of AI in drug discovery is not a confident answer on a screen. It is a better experiment, a clearer decision, and a hypothesis that survives contact with biology.
Our research direction connects molecular modeling, therapeutic design, and experimental learning—with uncertainty made visible at every step.
Explore our research priorities